PMCTPharmaCountry
    ホーム

規制動向

FDA、EMA、TGA および世界の規制動向

#dexamethasone ×

UPDATED
規制動向
2026年9月25日•1分で読めます
FDA Approves Dexamethasone Sodium Phosphate Injection (ANDA 084282)
The FDA has approved ANDA 084282 for Dexamethasone Sodium Phosphate injectable, a prescription drug manufactured by Hikma and Civica with multiple NDC listings.
UPDATED
規制動向
2026年8月29日•1分で読めます
Watson Labs' Dexamethasone Sodium Phosphate Injection Discontinued (ANDA083702)
Watson Labs' injectable dexamethasone sodium phosphate (product 001) is listed as discontinued per FDA ANDA083702 filing.